Tiziana Life Sciences Ltd

TLSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001723069

Price chart

Open-market purchases and sales by TLSA insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Aug 7, 20264:16 PM ETAmendedJul 21, 2026CERRONE GABRIELE MDirector, 10% OwnerPPurchaseCOMMON STOCK+42.36K$0.99+$41.93K44.81M+0.1%SEC
Aug 7, 20264:15 PM ETAmendedJun 12, 2026CERRONE GABRIELE MDirector, 10% OwnerPPurchaseCOMMON STOCK+15K$1.11+$16.65K44.77M0.0%SEC
Aug 6, 20269:30 AM ETAug 4 – Aug 5, 2026Elrifi IvorChief Executive OfficerPPurchaseCOMMON STOCK+321.42K$0.9922+$318.91K4.79M+7.2%SEC
Aug 5, 20264:30 PM ETAug 3, 2026Elrifi IvorChief Executive OfficerPPurchaseCOMMON STOCK+667K$1.00+$667K4.47M+17.5%SEC

The largest institutional positions in TLSA at the end of Q2 2026.

Institutions holding TLSA in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Dauntless Investment Group, LLC1,162,000$1.49M2.58%−1,003,231−46.3%Reduced
Mid-American Wealth Advisory Group, Inc.323,240$413.75K0.15%+323,240New
Zhang Financial LLC125,950$161.22K0.00%+14,050+12.6%Added
GOLDMAN SACHS GROUP INC119,238$152.63K0.00%+43,578+57.6%Added
CITADEL ADVISORS LLC80,222$102.68K0.00%+45,128+128.6%Added